Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Investment approach | Long-only |
| Index | iSTOXX® FactSet Breakthrough Healthcare |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | GBP 1,200 m |
| Total expense ratio | 0.40% p.a. |
| Replication | Physical (Optimized sampling) |
| Legal structure | ETF |
| Sustainability | Yes |
| Fund currency | USD |
| Currency hedged | No |
| Inception/ Listing Date | 8 September 2016 |
| Distribution policy | Accumulating |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| UK | UK Reporting |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| Italy | 26.0% |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 31 May |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | Yes |
| Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
| Moderna, Inc. | 4.90% |
| Natera | 2.26% |
| Illumina, Inc. | 2.07% |
| IQVIA Holdings | 1.75% |
| Genmab A/S | 1.73% |
| Revvity | 1.73% |
| Guardant Health | 1.66% |
| Agilent Technologies | 1.54% |
| Roivant Sciences Ltd. | 1.53% |
| Medpace Holdings | 1.50% |
| United States | 65.20% |
| Switzerland | 5.28% |
| Japan | 4.49% |
| United Kingdom | 3.86% |
| Other | 21.17% |
| Healthcare | 99.63% |
| Business Services | 0.17% |
| Finance | 0.00% |
| Other | 0.20% |
| YTD | +21.56% |
| 1 month | -2.05% |
| 3 months | +3.31% |
| 6 months | +25.50% |
| 1 year | +21.92% |
| 3 years | +51.78% |
| 5 years | +11.08% |
| Since inception (MAX) | +115.38% |
| 2025 | +10.23% |
| 2024 | +3.06% |
| 2023 | -3.45% |
| 2022 | -14.59% |
| Volatility 1 year | 17.52% |
| Volatility 3 years | 15.74% |
| Volatility 5 years | 18.58% |
| Return per risk 1 year | 1.25 |
| Return per risk 3 years | 0.95 |
| Return per risk 5 years | 0.11 |
| Maximum drawdown 1 year | -12.52% |
| Maximum drawdown 3 years | -20.12% |
| Maximum drawdown 5 years | -31.60% |
| Maximum drawdown since inception | -38.73% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Euronext Paris | EUR | HEAL | - - | - - | - |
| gettex | EUR | 2B78 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | 2B78 | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | HEALN MM | HEALN.MX | |
| Borsa Italiana | EUR | HEAL | HEAL IM INAVHEAE | HEAL.MI | |
| Euronext Amsterdam | EUR | HEAL | HEAL NA | ||
| London Stock Exchange | GBX | DRDR | DRDR LN INAVHEAG | DRDR.L 0O62INAV.DE | |
| London Stock Exchange | USD | HEAL | HEAL LN INAVHEAU | HEAL.L 0O64INAV.DE | |
| London Stock Exchange | GBP | - | DRDR LN INAVHEAG | DRDR.L 0O62INAV.DE | |
| SIX Swiss Exchange | USD | HEAL | HEAL SE INAVHEAU | HEAL.S 0O64INAV.DE | |
| XETRA | EUR | 2B78 | 2B78 GY INAVHEAE | 2B78.DE 0O60INAV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 21 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 14 | 0.30% p.a. | Accumulating | Full replication |